|
2018 Journal Article Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03Poulsen, Michael, Macfarlane, David, Veness, Michael, Estall, Venessa, Hruby, George, Kumar, Mahesh, Pullar, Andrew, Tripcony, Lee and Rischin, Danny (2018). Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03. Journal of Medical Imaging and Radiation Oncology, 62 (3), 412-419. doi: 10.1111/1754-9485.12705 |
|
2015 Journal Article A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancersBurge, Matthew E., O'Rourke, Nick, Cavallucci, David, Bryant, Richard, Francesconi, Alessandra, Houston, Kathleen, Wyld, David, Eastgate, Melissa, Finch, Robert, Hopkins, George, Thomas, Paul and Macfarlane, David (2015). A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers. HPB, 17 (7), 624-631. doi: 10.1111/hpb.12418 |
|
2015 Journal Article Blood–brain barrier dysfunction following traumatic brain injury: correlation of Ktrans (DCE-MRI) and suvr (99mTc-DTPA SPECT) but not serum S100BWinter, Craig, Bell, Christopher, Whyte, Timothy, Cardinal, John, Macfarlane, David and Rose, Stephen (2015). Blood–brain barrier dysfunction following traumatic brain injury: correlation of Ktrans (DCE-MRI) and suvr (99mTc-DTPA SPECT) but not serum S100B. Neurological Research, 37 (7), 599-606. doi: 10.1179/1743132815Y.0000000018 |
|
2013 Journal Article Alpha emitter radium-223 and survival in metastatic prostate cancerParker, C, Nilsson, S, Heinrich, D, Helle, S I, O'Sullivan, J M, Fosså, S D, Chodacki, A, Wiechno, P, Logue, J, Seke, M, Widmark, A, Johannessen, D C, Hoskin, P, Bottomley, D, James, N D, Solberg, A, Syndikus, I, Kliment, J, Wedel, S, Boehmer, S, Dall'Oglio, M, Franzén, L, Coleman, R, Vogelzang, N J, O'Bryan-Tear, C G, Staudacher, K, Garcia-Vargas, J, Shan, M, Bruland, Ø S ... Macfarlane, David (ALSYMPCA Investigators member) (2013). Alpha emitter radium-223 and survival in metastatic prostate cancer. The New England Journal of Medicine, 369 (3), 213-223. doi: 10.1056/NEJMoa1213755 |
|
2013 Journal Article The 'double pituitary hot spot' sign of skull base meningioma on gallium-68-labelled somatostatin analogue PETLaw, W.P., Fiumara, F., Fong, W. and MacFarlane, D.J. (2013). The 'double pituitary hot spot' sign of skull base meningioma on gallium-68-labelled somatostatin analogue PET. Journal of Medical Imaging and Radiation Oncology, 57 (6), 680-683. doi: 10.1111/1754-9485.12069 |
|
2011 Journal Article Detection of Pulmonary Emboli With 99mTc-Labeled Anti-D-dimer (DI-80B3)Fab' Fragments (ThromboView)Morris, Timothy A., Gerometta, Michael, Yusen, Roger D., White, Richard H., Douketis, James D., Kaatz, Scott, Smart, Richard C., Macfarlane, David and Ginsberg, Jeffrey S. (2011). Detection of Pulmonary Emboli With 99mTc-Labeled Anti-D-dimer (DI-80B3)Fab' Fragments (ThromboView). American Journal of Respiratory and Critical Care Medicine, 184 (6), 708-714. doi: 10.1164/rccm.201104-0624OC |
|
2011 Journal Article Pulmonary Emboli Imaging with 99mTc-labelled Anti-D-dimer (DI-80B3) Fab′ Followed by SPECTMorris, Timothy A., Gerometta, Michael, Smart, Richard C., Eisenberg, Paul, Roach, Paul J., Tsui, Wendy W., Better, Nathan, Taubman, Kim L., Unger, Steven A. and Macfarlane, David (2011). Pulmonary Emboli Imaging with 99mTc-labelled Anti-D-dimer (DI-80B3) Fab′ Followed by SPECT. Heart, Lung and Circulation, 20 (8), 503-511. doi: 10.1016/j.hlc.2011.03.113 |
|
2011 Journal Article Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinibMileshkin, Linda, Hicks, Rodney J., Hughes, Brett G. M., Mitchell, Paul L. R., Charu, Veena, Gitlitz, Barbara J., Macfarlane, David, Solomon, Benjamin, Amler, Lukas C., Yu, Wei, Pirzkall, Andrea and Fine, Bernard M. (2011). Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinib. Clinical Cancer Research, 17 (10), 3304-3315. doi: 10.1158/1078-0432.CCR-10-2763 |
|
2011 Journal Article Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancerBinns, David S., Pirzkall, Andrea, Yu, Wei, Callahan, Jason, Mileshkin, Linda, Conti, Peter, Scott, Andrew M., Macfarlane, David, Fine, Bernard M., Hicks, Rodney J. and OSI3926g Study Team (2011). Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging, 38 (4), 642-650. doi: 10.1007/s00259-010-1665-0 |
|
2011 Journal Article Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapyPorceddu, Sandro V., Pryor, David I., Burmeister, Elizabeth, Burmeister, Bryan H., Poulsen, Michael G., Foote, Matthew C., Panizza, Benedict, Coman, Scott, McFarlane, David and Coman, William (2011). Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy. Head and Neck, 33 (12), 1675-1682. doi: 10.1002/hed.21655 |
|
2009 Journal Article Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancersHerbertson, Rebecca A., Tebbutt, Niall C., Lee, Fook-Thean, MacFarlane, David J., Chappell, Bridget, Micallef, Noel, Lee, Sze-Ting, Saunder, Timothy, Hopkins, Wendie, Smyth, Fiona E., Wyld, David K., Bellen, John, Sonnichsen, Daryl S., Brechbiel, Martin W., Murone, Carmel and Scott, Andrew M. (2009). Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers. Clinical Cancer Research, 15 (21), 6709-6715. doi: 10.1158/1078-0432.CCR-09-0536 |
|
2009 Journal Article Nesidioblastosis as a cause of focal pancreatic 111In-pentetreotide uptake in a patient with putative VIPoma: another differential diagnosisFrancesconi, Alessandra Bastian, Matos, Marco, Lee, Joseph C., Wyld, David K., Clouston, Andrew D. and Macfarlane, David (2009). Nesidioblastosis as a cause of focal pancreatic 111In-pentetreotide uptake in a patient with putative VIPoma: another differential diagnosis. Annals of Nuclear Medicine, 23 (5), 497-499. doi: 10.1007/s12149-009-0252-6 |
|
2009 Journal Article Imaging of deep venous thrombosis in patients using a radiolabelled anti-D-dimer Fab′ fragment (99mTc-DI-DD3B6/22-80B3): results of a phase I trialMacfarlane, David, Socrates, Angelides, Eisenberg, Paul, Larcos, George, Roach, Paul, Gerometta, Michael, Smart, Richard, Tsui, Wendy and Scott, Andrew M. (2009). Imaging of deep venous thrombosis in patients using a radiolabelled anti-D-dimer Fab′ fragment (99mTc-DI-DD3B6/22-80B3): results of a phase I trial. European Journal of Nuclear Medicine and Molecular Imaging, 36 (2), 250-259. doi: 10.1007/s00259-008-0934-7 |
|
2006 Journal Article Metastatic paraganglioma with extensive bone marrow involvementMorris, Kirk L., Macfarlane, David, Wyld, David and Kennedy, Glen A. (2006). Metastatic paraganglioma with extensive bone marrow involvement. Asia-Pacific Journal of Clinical Oncology, 2 (4), 193-194. doi: 10.1111/j.1743-7563.2006.00068.x |
|
2006 Journal Article Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6/22-80B3 Fab 'Macfarlane, David J., Smart, Richard C., Tsui, Wendy W., Gerometta, Michael, Eisenberg, Paul R. and Scott, Andrew M. (2006). Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6/22-80B3 Fab '. European Journal of Nuclear Medicine and Molecular Imaging, 33 (6), 648-656. doi: 10.1007/s00259-005-0025-y |
|
2005 Journal Article Outcome of myeloablative allogeneic stem cell transplantation in multiple myeloma with a Sm-153-EDTMP-based preparative regimenKennedy, G. A., Durrant, S., Butler, J., Morton, J., Western, R., Bartlett, M. L., Allison, R. and MacFarlane, D. J. (2005). Outcome of myeloablative allogeneic stem cell transplantation in multiple myeloma with a Sm-153-EDTMP-based preparative regimen. Leukemia, 19 (5), 879-880. doi: 10.1038/sj.leu.2403698 |
|
2004 Journal Article Therapeutic activation of V alpha 24(+)V beta 11(+) NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunityNieda, M, Okai, M, Tazbirkova, A, Lin, H, Yamaura, A, Ide, K, Abraham, R, Juji, T, Macfarlane, DJ and Nicol, AJ (2004). Therapeutic activation of V alpha 24(+)V beta 11(+) NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood, 103 (2), 383-389. doi: 10.1182/blood-2003-04-1155 |
|
2002 Journal Article Sm-153 EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignanciesMacfarlane, DJ, Durrant, S, Bartlett, ML, Allison, R and Morton, AJ (2002). Sm-153 EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignancies. Nuclear Medicine Communications, 23 (11), 1099-1106. doi: 10.1097/01.mnm.0000040978.43128.ae |
|
2002 Journal Article Dosimetry and toxicity of Quadramet for bone marrow ablation in multiple myeloma and other haematological malignanciesBartlett, Marissa L, Webb, Myles, Durrant, Simon, Morton, A James, Allison, Roger and Macfarlane, David J (2002). Dosimetry and toxicity of Quadramet for bone marrow ablation in multiple myeloma and other haematological malignancies. European Journal of Nuclear Medicine and Molecular Imaging, 29 (11), 1470-1477. doi: 10.1007/s00259-002-0934-y |
|
2002 Journal Article 153Sm EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignanciesMacfarlane, D. J., Durrant, S., Bartlett, M. L., Allison, R. and Morton, A. J. (2002). 153Sm EDTMP for bone marrow ablation prior to stem cell transplantation for haematological malignancies. Nuclear medicine communications, 23 (11), 1099-1106. doi: 10.1097/00006231-200211000-00010 |
